Trials / Completed
CompletedNCT00186342
Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies
Allogeneic Sibling and Unrelated Donor Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Busulfan, Etoposide and Cyclophosphamide
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 51 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the tolerability and efficacy in treating patients aged 51-60 with acute leukemia and in treating myelodysplastic syndromes (MDS) or myeloproliferative disorders (MPD).
Detailed description
To learn whether a new preparative regimen to prepare patients for bone marrow transplantation is useful in patients above 50 years of age and whether it is useful in patients with myelodysplastic syndromes.
Conditions
- Acute Disease
- Myelodysplastic Syndromes
- Leukemia, Myeloid, Chronic
- Myeloproliferative Disorders
- Blood and Marrow Transplant (BMT)
- Myelodysplastic Syndromes (MDS)
- Leukemia
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ablative allogeneic hematopoietic cell transplantation |
Timeline
- Start date
- 1992-09-01
- Primary completion
- 2009-01-01
- Completion
- 2009-01-01
- First posted
- 2005-09-16
- Last updated
- 2012-12-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00186342. Inclusion in this directory is not an endorsement.